drugset / Trial / NCT00548340
VEC-162 Study in Adult Patients With Primary Insomnia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of a 5 week double-blind treatment period of VEC-162 as compared to placebo in male and female patients with primary insomnia.
Timeline
- Start
- 2007-11
- Primary completion
- 2008-02
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tasimelteon | Small molecule | 20 mg | Oral |
| Subject | tasimelteon | Small molecule | 50 mg | Oral |